Baird MWA Generator
Controlled MWA energy for efficient ablation workflows
The Baird microwave ablation (MWA) generator combines adjustable microwave output, integrated cooling, and real-time temperature monitoring.
Manufactured by Betters (Suzhou) Medical Co., Ltd. · U.S. sales and support by Baird Medical LLC.
2450 MHz
0–70 W
Maximum 60 W with T-series needles
3 modes
Built-in
Real-time
The Microwave Ablation System (BD-GT) is FDA-cleared for the coagulation (ablation) of soft tissue and supports physician-directed control from setup through energy delivery.
Energy delivery
No grounding pad required
The Baird MWA system delivers 2450 MHz microwave energy through a Baird MWA needle to generate heat within tissue. Unlike monopolar RF ablation, it does not require a grounding pad to complete an electrical circuit through the patient.
Output modes
Three output modes
Foot mode
Foot-switch activation supports hands-free microwave output when the clinician's hands are occupied at the sterile field or imaging interface.
- External foot switch
- 1–99 s
- Physician-directed
Interface visibility
Stay informed. Stay in control.
Power, time, operating mode, temperature, and cooling status stay visible in one real-time view. Visual and audible alerts indicate abnormal conditions, helping you stay focused and in control throughout the procedure.
Cooling & monitoring
Built-in cooling with temperature safeguards
Cooling is built into the system’s energy-delivery sequence. A peristaltic pump circulates water or saline through Baird MWA needles, and microwave output is enabled only after cooling is active. Real-time temperature monitoring and over-temperature protection work together to support controlled MWA delivery throughout treatment.
Bring controlled MWA into your workflow
Talk with the Baird Medical team about system fit, training, implementation, and ongoing support for your MWA program.
Indications & Safety
Rx only. The Microwave Ablation System (BD-GT) is indicated for coagulation (ablation) of soft tissue. Not intended for cardiac use. Contraindicated in patients with massive bleeding tendency; not recommended for pregnant women; use caution in patients with severe coagulation dysfunction. Potential risks and complications include pain, bleeding or hematoma, swelling, thyroid-function changes, voice changes, and injury to nearby structures. Refer to the Safety Information and the Instructions for Use.
FDA 510(k) K232240 · Class II